Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Apr;37(4):889–892. doi: 10.1128/aac.37.4.889

Curative and preventive anticryptosporidium activities of sinefungin in an immunosuppressed adult rat model.

P Brasseur 1, D Lemeteil 1, J J Ballet 1
PMCID: PMC187800  PMID: 8494386

Abstract

An immunosuppressed rat model was used to investigate the anti-Cryptosporidium parvum activity of sinefungin. In infected animals, oral sinefungin therapy resulted in a dose-related suppression of oocyst shedding, which correlated with oocyst disappearance from ileal sections. When administered prior to or on the day of oocyst challenge, sinefungin successfully prevented infection. These data suggest that sinefungin could be considered as a candidate molecule in the treatment of human cryptosporidiosis, considered to be the most significant enteric opportunistic infection in AIDS.

Full text

PDF
889

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachrach U., Schnur L. F., El-On J., Greenblatt C. L., Pearlman E., Robert-Gero M., Lederer E. Inhibitory activity of sinefungin and SIBA (5'-deoxy-5'-S-isobutylthio-adenosine) on the growth of promastigotes and amastigotes of different species of Leishmania. FEBS Lett. 1980 Dec 1;121(2):287–291. doi: 10.1016/0014-5793(80)80364-4. [DOI] [PubMed] [Google Scholar]
  2. Barton D. H., Géro S. D., Lawrence F., Robert-Gero M., Quiclet-Sire B., Samadi M. Total synthesis of uracil analogues of sinefungin. J Med Chem. 1992 Jan;35(1):63–67. doi: 10.1021/jm00079a007. [DOI] [PubMed] [Google Scholar]
  3. Blanchard P., Dodic N., Fourrey J. L., Lawrence F., Mouna A. M., Robert-Gero M. Synthesis and biological activity of sinefungin analogues. J Med Chem. 1991 Sep;34(9):2798–2803. doi: 10.1021/jm00113a018. [DOI] [PubMed] [Google Scholar]
  4. Brasseur P., Lemeteil D., Ballet J. J. Anti-cryptosporidial drug activity screened with an immunosuppressed rat model. J Protozool. 1991 Nov-Dec;38(6):230S–231S. [PubMed] [Google Scholar]
  5. Brasseur P., Lemeteil D., Ballet J. J. Rat model for human cryptosporidiosis. J Clin Microbiol. 1988 May;26(5):1037–1039. doi: 10.1128/jcm.26.5.1037-1039.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brasseur P., Lemeteil D., Mallet E. La cryptosporidiose chez l'enfant immunocompétent. Presse Med. 1987 Feb 7;16(4):177–177. [PubMed] [Google Scholar]
  7. Current W. L., Garcia L. S. Cryptosporidiosis. Clin Microbiol Rev. 1991 Jul;4(3):325–358. doi: 10.1128/cmr.4.3.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dube D. K., Mpimbaza G., Allison A. C., Lederer E., Rovis L. Antitrypanosomal activity of sinefungin. Am J Trop Med Hyg. 1983 Jan;32(1):31–33. doi: 10.4269/ajtmh.1983.32.31. [DOI] [PubMed] [Google Scholar]
  9. Ferrante A., Ljungström I., Huldt G., Lederer E. Amoebicidal activity of the antifungal antibiotic sinefungin against Entamoeba histolytica. Trans R Soc Trop Med Hyg. 1984;78(6):837–838. doi: 10.1016/0035-9203(84)90039-7. [DOI] [PubMed] [Google Scholar]
  10. Ferrante A., Ljungström I., Lederer E. Antitoxoplasmosis properties of sinefungin in mice. C R Acad Sci III. 1988;306(3):109–113. [PubMed] [Google Scholar]
  11. Flanigan T. P., Aji T., Marshall R., Soave R., Aikawa M., Kaetzel C. Asexual development of Cryptosporidium parvum within a differentiated human enterocyte cell line. Infect Immun. 1991 Jan;59(1):234–239. doi: 10.1128/iai.59.1.234-239.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gordee R. S., Butler T. F. A9145, a new adenine-containing antifungal antibiotic. II. Biological activity. J Antibiot (Tokyo) 1973 Aug;26(8):466–470. doi: 10.7164/antibiotics.26.466. [DOI] [PubMed] [Google Scholar]
  13. Heine J. Eine einfache Nachweismethode für Kryptosporidien im Kot. Zentralbl Veterinarmed B. 1982 May;29(4):324–327. [PubMed] [Google Scholar]
  14. Kassa M., Comby E., Lemeteil D., Brasseur P., Ballet J. J. Characterization of anti-Cryptosporidium IgA antibodies in sera from immunocompetent individuals and HIV-infected patients. J Protozool. 1991 Nov-Dec;38(6):179S–180S. [PubMed] [Google Scholar]
  15. Kim C. W. Chemotherapeutic effect of arprinocid in experimental cryptosporidiosis. J Parasitol. 1987 Jun;73(3):663–666. [PubMed] [Google Scholar]
  16. Kimata I., Uni S., Iseki M. Chemotherapeutic effect of azithromycin and lasalocid on Cryptosporidium infection in mice. J Protozool. 1991 Nov-Dec;38(6):232S–233S. [PubMed] [Google Scholar]
  17. Messika E., Golenser J., Abu-Elheiga L., Robert-Gero M., Lederer E., Bachrach U. Effect of sinefungin on macromolecular biosynthesis and cell cycle of Plasmodium falciparum. Trop Med Parasitol. 1990 Sep;41(3):273–278. [PubMed] [Google Scholar]
  18. Nadler J. P., Lederer E., Wittner M., Baum S. G., Tanowitz H. B. The effect of adenosine analogues on the in vitro growth of Trypanosoma cruzi. Trans R Soc Trop Med Hyg. 1982;76(3):285–287. doi: 10.1016/0035-9203(82)90169-9. [DOI] [PubMed] [Google Scholar]
  19. Reese N. C., Current W. L., Ernst J. V., Bailey W. S. Cryptosporidiosis of man and calf: a case report and results of experimental infections in mice and rats. Am J Trop Med Hyg. 1982 Mar;31(2):226–229. doi: 10.4269/ajtmh.1982.31.226. [DOI] [PubMed] [Google Scholar]
  20. Rekg J. E., Hancock M. L., Woodmansee D. B. Anticryptosporidial activity of sulfadimethoxine. Antimicrob Agents Chemother. 1988 Dec;32(12):1907–1908. doi: 10.1128/aac.32.12.1907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Trager W., Tershakovec M., Chiang P. K., Cantoni G. L. Plasmodium falciparum: antimalarial activity in culture of sinefungin and other methylation inhibitors. Exp Parasitol. 1980 Aug;50(1):83–89. doi: 10.1016/0014-4894(80)90010-7. [DOI] [PubMed] [Google Scholar]
  22. Ungar B. L., Burris J. A., Quinn C. A., Finkelman F. D. New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infect Immun. 1990 Apr;58(4):961–969. doi: 10.1128/iai.58.4.961-969.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ungar B. L., Ward D. J., Fayer R., Quinn C. A. Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology. 1990 Feb;98(2):486–489. doi: 10.1016/0016-5085(90)90842-o. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES